Henlius R&D Day 2025: Collaboration Drives Global Innovation Strategy Forward Henlius held its 2025 Global R&D Day under the theme 'Collaborate to Create,' showcasing innovative therapies and strategic growth.

Henlius R&D Day 2025: Collaboration Drives Global Innovation Strategy Forward #China #Shanghai #Henlius #Serplulimab #HLX22

Henlius Biotech's HLX22 Receives Orphan Drug Designation for Gastric Cancer Treatment in the U.S. Shanghai Henlius Biotech announces that the FDA has granted Orphan Drug Designation to HLX22, its promising anti-HER2 antibody, for gastric cancer treatment.

Henlius Biotech's HLX22 Receives Orphan Drug Designation for Gastric Cancer Treatment in the U.S. #China #Shanghai #Henlius #Henlius_Biotech #HLX22